Pre-transplant higher serum levels of CRP and IL-6 observed in our CEPH group seem to support this hypothesis, as they may not only reflect systemic inflammation but were also shown to correlate with immune status at the tumor site [27,28]. Here, IL6 is linked to neoplasm.